These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 29679556)
21. Small-molecule SMAC mimetics as new cancer therapeutics. Bai L; Smith DC; Wang S Pharmacol Ther; 2014 Oct; 144(1):82-95. PubMed ID: 24841289 [TBL] [Abstract][Full Text] [Related]
22. The radiosensitizing activity of the SMAC-mimetic, Debio 1143, is TNFα-mediated in head and neck squamous cell carcinoma. Matzinger O; Viertl D; Tsoutsou P; Kadi L; Rigotti S; Zanna C; Wiedemann N; Vozenin MC; Vuagniaux G; Bourhis J Radiother Oncol; 2015 Sep; 116(3):495-503. PubMed ID: 26096848 [TBL] [Abstract][Full Text] [Related]
23. Smac mimetics as new cancer therapeutics. Chen DJ; Huerta S Anticancer Drugs; 2009 Sep; 20(8):646-58. PubMed ID: 19550293 [TBL] [Abstract][Full Text] [Related]
25. SMAC mimetics sensitize nonsteroidal anti-inflammatory drug-induced apoptosis by promoting caspase-3-mediated cytochrome c release. Bank A; Wang P; Du C; Yu J; Zhang L Cancer Res; 2008 Jan; 68(1):276-84. PubMed ID: 18172320 [TBL] [Abstract][Full Text] [Related]
26. Smac mimetic and oleanolic acid synergize to induce cell death in human hepatocellular carcinoma cells. Liese J; Abhari BA; Fulda S Cancer Lett; 2015 Aug; 365(1):47-56. PubMed ID: 25917078 [TBL] [Abstract][Full Text] [Related]
27. Antitumor activity of a novel homodimeric SMAC mimetic in ovarian carcinoma. Gatti L; De Cesare M; Ciusani E; Corna E; Arrighetti N; Cominetti D; Belvisi L; Potenza D; Moroni E; Vasile F; Lecis D; Delia D; Castiglioni V; Scanziani E; Seneci P; Zaffaroni N; Perego P Mol Pharm; 2014 Jan; 11(1):283-93. PubMed ID: 24256025 [TBL] [Abstract][Full Text] [Related]
28. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner. Wagner L; Marschall V; Karl S; Cristofanon S; Zobel K; Deshayes K; Vucic D; Debatin KM; Fulda S Oncogene; 2013 Feb; 32(8):988-97. PubMed ID: 22469979 [TBL] [Abstract][Full Text] [Related]
29. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC. Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687 [TBL] [Abstract][Full Text] [Related]
30. Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft models. Benetatos CA; Mitsuuchi Y; Burns JM; Neiman EM; Condon SM; Yu G; Seipel ME; Kapoor GS; Laporte MG; Rippin SR; Deng Y; Hendi MS; Tirunahari PK; Lee YH; Haimowitz T; Alexander MD; Graham MA; Weng D; Shi Y; McKinlay MA; Chunduru SK Mol Cancer Ther; 2014 Apr; 13(4):867-79. PubMed ID: 24563541 [TBL] [Abstract][Full Text] [Related]
31. Over-expression of Smac promotes TRAIL-induced cell death in human hepatocellular carcinoma. Okano H; Shiraki K; Inoue H; Kawakita T; Saitou Y; Enokimura N; Yamamoto N; Sugimoto K; Fujikawa K; Murata K; Nakano T Int J Mol Med; 2003 Jul; 12(1):25-8. PubMed ID: 12792804 [TBL] [Abstract][Full Text] [Related]
32. Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells. Grabinger T; Bode KJ; Demgenski J; Seitz C; Delgado ME; Kostadinova F; Reinhold C; Etemadi N; Wilhelm S; Schweinlin M; Hänggi K; Knop J; Hauck C; Walles H; Silke J; Wajant H; Nachbur U; W Wei-Lynn W; Brunner T Gastroenterology; 2017 Mar; 152(4):867-879. PubMed ID: 27889570 [TBL] [Abstract][Full Text] [Related]
33. Reactivation of Smac-mediated apoptosis in chronic lymphocytic leukemia cells: mechanistic studies of Smac mimetic. Balakrishnan K; Fu M; Onida F; Wierda WG; Keating MJ; Gandhi V Oncotarget; 2016 Jun; 7(26):39458-39472. PubMed ID: 27223062 [TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase-2 inhibitor and interferon-beta synergistically induce apoptosis in human hepatoma cells in vitro and in vivo. Nakamoto N; Higuchi H; Kanamori H; Kurita S; Tada S; Takaishi H; Toda K; Yamada T; Kumagai N; Saito H; Hibi T Int J Oncol; 2006 Sep; 29(3):625-35. PubMed ID: 16865278 [TBL] [Abstract][Full Text] [Related]
35. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma. Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975 [TBL] [Abstract][Full Text] [Related]
36. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma. Bao ST; Gui SQ; Lin MS Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346 [TBL] [Abstract][Full Text] [Related]
37. Anti-HBV drugs suppress the growth of HBV-related hepatoma cells via down-regulation of hepatitis B virus X protein. Zhang S; Gao S; Zhao M; Liu Y; Bu Y; Jiang Q; Zhao Q; Ye L; Zhang X Cancer Lett; 2017 Apr; 392():94-104. PubMed ID: 28192212 [TBL] [Abstract][Full Text] [Related]
38. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism. Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169 [TBL] [Abstract][Full Text] [Related]
40. Hypoxia-mediated sorafenib resistance can be overcome by EF24 through Von Hippel-Lindau tumor suppressor-dependent HIF-1α inhibition in hepatocellular carcinoma. Liang Y; Zheng T; Song R; Wang J; Yin D; Wang L; Liu H; Tian L; Fang X; Meng X; Jiang H; Liu J; Liu L Hepatology; 2013 May; 57(5):1847-57. PubMed ID: 23299930 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]